Clinical Trials
24 trialsNCT05020652 2026-06-02
A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2 Completed
NCT07599033 2026-05-22
PAPE-MID
Inonu University
Phase NA Completed
NCT02362035 2026-05-13
KEYNOTE145
Acerta Pharma BV
Phase 1/2 Completed
NCT05169658 2026-05-13
Mosunetuzumab With or Without Polatuzumab Vedotin and Obinutuzumab for the Treatment of Untreated Indolent B-Cell Non-Hodgkin Lymphoma
University of Washington
Phase 2 Completed
NCT01208896 2026-05-12
RITALLO
University Hospital, Bordeaux
Phase 2 Completed
NCT04205409 2026-05-12
Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies
University of Washington
Phase 2 Completed
NCT05919069 2026-05-11
A Phase I Study to Investigate the Effect of Hepatic Impairment on the PK, Safety, and Tolerability of AZD2693
AstraZeneca
Phase 1 Completed
NCT04680117 2026-05-06
SevAsthma
Assistance Publique - Hôpitaux de Paris
Phase NA Completed
NCT07530952 2026-05-05
VR&depression
Sykehuset Innlandet HF
Phase NA Completed
NCT00641381 2026-05-04
Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma
City of Hope Medical Center
Phase 1 Completed
NCT03035331 2026-05-04
Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma
Mayo Clinic
Phase 1/2 Completed
NCT05818423 2026-04-29
Brain Health Together: A Live-Streaming Group-Based Digital Program
University of California, San Francisco
Phase NA Completed
NCT06934109 2026-04-29
Narrative Exposure Therapy for Adults With an Intellectual Disability
University of Nottingham
Phase NA Completed
NCT02315612 2026-04-28
Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT03341520 2026-04-17
GAZAI
Heidelberg University
Phase 2 Completed
NCT03536975 2026-04-17
CAREGIVERSPRO
University Hospital, Rouen
Phase NA Completed
NCT01384513 2026-04-15
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Phase 2 Completed
NCT04488354 2026-04-08
Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T
Calibr, a division of Scripps Research
Phase 1 Completed
NCT00428142 2026-03-27
Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma
Canadian Cancer Trials Group
Phase 2 Completed
NCT04087798 2026-03-27
CHECK-D
University of Michigan
Phase NA Completed
NCT05860127 2026-03-23
Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial
University of Massachusetts, Amherst
Phase NA Completed
NCT05962606 2026-03-18
Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.
Aptarion Biotech AG
Phase 2 Completed
NCT02947347 2026-03-17
Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
Pharmacyclics LLC.
Phase 3 Completed
NCT00006721 2026-03-16
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
SWOG Cancer Research Network
Phase 3 Completed